Literature DB >> 25650553

No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance.

D J Groeneveld1, T van Bekkum, K L Cheung, R J Dirven, G Castaman, P H Reitsma, B van Vlijmen, J Eikenboom.   

Abstract

BACKGROUND: One of the major determinants of von Willebrand factor (VWF) plasma levels is ABO blood group status, and individuals with blood group O have ~ 25% lower plasma levels. The exact mechanism behind this relationship remains unknown, although effects on clearance have been postulated.
OBJECTIVES: To determine whether clearance of VWF is directly dependent on the presence of ABH antigens on VWF.
METHODS: Three type 3 von Willebrand disease (VWD) patients were infused with Haemate-P, and the relative loading of VWF with ABH antigens at different time points was measured. VWF-deficient mice were injected with purified plasma-derived human VWF obtained from donors with either blood group A, blood group B, or blood group O.
RESULTS: In mice, we found no difference in clearance rate between plasma-derived blood group A, blood group B and blood group O VWF. Faster clearance of the blood group O VWF present in Haemate-P infused in type 3 VWD patients would have resulted in a relative increase in the loading of VWF with A and B antigens over time. However, we observed a two-fold decrease in the loading with A and B antigens in two out of three patients, and stable loading in the third patient.
CONCLUSION: There is no direct effect of ABH antigens on VWF in VWF clearance. We demonstrate that, in a direct comparison within one individual, blood group O VWF is not cleared faster than blood group A or blood group B VWF. Clearance differences between blood group O and non-blood group O individuals may therefore be related to the blood group status of the individual rather than the ABH antigen loading on VWF itself.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  ABO blood-group system; blood group antigens; type 3 VWD; von Willebrand disease; von Willebrand factor

Mesh:

Substances:

Year:  2015        PMID: 25650553     DOI: 10.1111/jth.12867

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  9 in total

1.  Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.

Authors:  A B Ozel; B McGee; D Siemieniak; P M Jacobi; S L Haberichter; L C Brody; J L Mills; A M Molloy; D Ginsburg; J Z Li; K C Desch
Journal:  J Thromb Haemost       Date:  2016-08-19       Impact factor: 5.824

2.  The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen.

Authors:  Laura L Swystun; Kenichi Ogiwara; Jesse D Lai; Juha R M Ojala; Orla Rawley; Fanny Lassalle; Colleen Notley; Olle Rengby; Alison Michels; Kate Nesbitt; Karl Tryggvason; David Lillicrap
Journal:  J Thromb Haemost       Date:  2019-06-20       Impact factor: 5.824

3.  Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.

Authors:  S Albánez; K Ogiwara; A Michels; W Hopman; J Grabell; P James; D Lillicrap
Journal:  J Thromb Haemost       Date:  2016-04-27       Impact factor: 5.824

Review 4.  Genetic regulation of plasma von Willebrand factor levels in health and disease.

Authors:  L L Swystun; D Lillicrap
Journal:  J Thromb Haemost       Date:  2018-10-30       Impact factor: 5.824

5.  Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice.

Authors:  Dafna Groeneveld; Holly Cline-Fedewa; Kevin S Baker; Kurt J Williams; Robert A Roth; Karen Mittermeier; Ton Lisman; Joseph S Palumbo; James P Luyendyk
Journal:  J Hepatol       Date:  2019-10-10       Impact factor: 30.083

6.  von Willebrand Factor: A Central Regulator of Arteriovenous Fistula Maturation Through Smooth Muscle Cell Proliferation and Outward Remodeling.

Authors:  Suzanne L Laboyrie; Margreet R de Vries; Alwin de Jong; Hetty C de Boer; Reshma A Lalai; Laisel Martinez; Roberto I Vazquez-Padron; Joris I Rotmans
Journal:  J Am Heart Assoc       Date:  2022-08-05       Impact factor: 6.106

Review 7.  The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.

Authors:  Soracha E Ward; Jamie M O'Sullivan; James S O'Donnell
Journal:  Blood       Date:  2020-12-17       Impact factor: 22.113

Review 8.  Role of fluid shear stress in regulating VWF structure, function and related blood disorders.

Authors:  Shobhit Gogia; Sriram Neelamegham
Journal:  Biorheology       Date:  2015       Impact factor: 1.875

Review 9.  Regulation of plasma von Willebrand factor.

Authors:  Karl C Desch
Journal:  F1000Res       Date:  2018-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.